HIV

The United States has approved a twice-a-year jab that almost entirely protects against HIV in what’s being hailed as a “breakthrough moment” for efforts to curb the virus.

1 Mins read
Reading Time: < 1 minute

Lenacapavir was developed by the US drug company Gilead - Nardus Engelbrecht/AP

The United States has approved a twice-a-year jab that almost entirely protects against HIV in what’s being hailed as a “breakthrough moment” for efforts to curb the virus.   Read More

Related posts
HIV

HIV, pregnancy, violence: The three-pronged crisis stealing the future of Africa's girls

1 Mins read
Reading Time: < 1 minuteMs Abigael* is not just a statistic. She is a young woman navigating three immediate threats to her life:  the risk of…
HIV

Zambia Must Decide Today: Open Minerals To American Firms Or Lose HIV Support For 1.3 Million

1 Mins read
Reading Time: < 1 minuteZambia must choose between granting US mineral access or losing crucial HIV treatment funding. Read More
HIV

Man cured of HIV through groundbreaking transplant from his brother in first-of-its-kind procedure

1 Mins read
Reading Time: < 1 minuteA man living with HIV has been cured of the devastating disease in a pioneering transplant, doctors have revealed. Read More
Subscribe to our Blog

Let's stay in touch. Subscribe to our blog and get our best content in your inbox. 

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.